AptarGroup, Inc.
ATR
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $8.1B
$127.41
▼ -0.70%
P/E
50.76
Mkt Cap
$8.1B
52-Wk Range
$103.23–$146.91
52-Week Range
$103.23 - $146.91
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 7.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
2 risks
- Low volatility (beta 0.4).
- Premium valuation to sector peers
Growth
Strong growth ahead
Value
Premium valuation to sector peers
Momentum
Strong
+13.8% over 3m
Quality
Stable
Strong fundamentals
Dividend
Modest
1.51% yield
Smart-money signal
Who's buying ATR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
JUL 30, 2026
Reported EPS of $1.42 vs $1.35 consensus (+5.2% surprise). Revenue of $1.0B vs $1.0B expected (+1.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+5.2%
Revenue trend · last 2Q
—
+6%
Q1 26
Q2 26
$982.9M
$1.0B
Margins · last 2Q
Gross
-26.9%
Operating
12.2%
Profit
8.5%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Raymond James · Jul 15, 2026
vs Industry
How ATR stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.